However, the mechanistic findings described here were most prominent in THP-1 cells; therefore, while NHE1 modulation may overcome venetoclax resistance in certain AML subsets, these results should not be generalized to all forms of AML. Here, SLC9A1 is linked to acute myeloid leukemia.